DOCSLIB.ORG

Sciencedirect.Com -,, JOURNALOF ·:;- Sciencedirect GENETICS and GENOMICS EI..SEVIER J

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Sciencedirect.Com -,, JOURNALOF ·:;- Sciencedirect GENETICS and GENOMICS EI..SEVIER J 7 Available online at www.sciencedirect.com -,, JOURNALOF ·:;- ScienceDirect GENETICS AND GENOMICS EI..SEVIER J. Genet. Genomics 36 (2009) 251-256 • www.jgenetgenornics.org Mutational screening of BASP 1 and transcribed processed pseudogene TP'Pg-BASP 1 in patients with Möbius syndrome 8 Abdullah Uzumcu 8, Sukru Candan , Guven Toksoy a, h, Z. Oya Uyguner 8, Birsen Karaman 8, Hacer Eris 8, Burak Tatli C, Hulya Kayserili 8, Adnan Yuksel d, Bilge Geckinli h, Memnune Yuksel-Apak 8, Seher Basaran a, • 'Department of Medica/ Genetics, /stanbul Medica/ Faculty, lstanbul University, lstanbul 34390, Turkey b Department ofGenetics, Zeynep Kamil Gyneco/ogic and Pediatric Training and Research Hospital, /stanbul 34668, Turkey • Division ofNeuro/ogy, Department ofPediatrics, /sıanbul Medica/ Facu/ty, lstanbul University, Istanbul 34390, Turkey d Department ofMedical Genetics, Ce"ahpasa Medica/ Faculty, lstanbul University, lstanbul 34098, Turkey Received for publication 11 July 2008; revised 30 December 2008; accepted 21 January 2009 Abstract Möbius syndrome is a rare disorder primarily characterized by congenital facia! palsy, frequently accompanied by ocular abduction anomalies and occasionally associated with orofacial, limb and musculoskeletal malfonnations. Abnormal development of cranial nerves V through XII underlines the disease pathogenesis. Although a genetic etiology for Möbius syndrome was proposed, molecular genetic studies to identify the causative gene(s) are scarce. in this study, we selected two candidate genes. One is BASPJ residing in a hwnan chromosome 5pl5.l-pl5.2, syntenic to mouse chromosome 15qA2-qB2, to which a mouse model with facia! nerve anomalies was mapped. The other is transcribed processed pseudogene TP'l'g-BASP 1, which is located on chromosome 13q flanking the putative locus for Möbius syndrome and might be involved in the regulation of the transcripts encoded by BASP 1. Mutation analyses in nineteen pa­ tients excluded these genes as being candidates for Möbius syndrome. Keywords: Möbius syndrome; facia! palsy; candidate gene; BASPI; transcribed processed pseudogene; non-coding RNA; mutation screening Introduction of the syndrome, whereas abducens nerve (CN VI) and hypoglossal nerve (CN XII) involvements are relatively Möbius syndrome (MBS) is a rare genetic disorder common (Strömland et al., 2002; Verzijl et al., 2003; Ames characterized by congenital facial palsy, frequently ac­ et al., 2005; Briegel, 2006). Although not yet completely companied by ocular abduction anomalies and occasion­ established, it has been suggested that the pathologicaJ ally associated with orofacial, limb and musculoskeletal mechanism underlying MBS is consistent with rhomben­ malformations. Abnormal development of cranial nerves cephalic maldevelopment involving predominantly motor (CNs) V through XII might be involved in the disease nuclei and axons, as well as traversing Iong tracts (Verzijl pathogenesis, either unilaterally or bilaterally. Primarily, et al., 2003). The etiology of MBS remains elusive. Vas­ abnormality in facia! nerve (CN VII) is the typical feature cular, teratogenic and genetic etiologies were proposed. Theories of vascular etiologies are mainly associated with • Corresponding author. Tel: +90-212-631 1363; Fax: +90-212-260 2283. disruption ofblood flow in the basilar artery (Samat, 2004), E-mail address: [email protected] premature regression of the primitive trigeminal arteries DOi: I0.1016/Sl673-8527(08)60112-5 ~------------~J l 252 Abdullah Uzumcu et al./ Journal o/Genelics and Genomics 36 (2009) 251-256 (Huerva et al., 1992), or disruption ofthe subclavian-artery mapped in a mouse model (Mar et al., 2005). TP'l'g­ supply (St Charles et al., 1993), alt of which interrupt the BASP I, which encodes for a non-coding RNA (ncRNA), embryonic blood supply. Strong association between ma­ was selected due to both relevancy of its location to the temal use of misoprostol and MBS was reported (Pas­ putative MBS locus on l 3q and its hypothesized role in the tuszak et al., 1998). Ergotamine (Smets et al., 2004) and regulation of BASP I transcripts. cocaine (Puvabanditsin et al., 2005) exposures during early fetal development were also suggested to be among the possible causes ofMBS. Material and methods A reciprocal translocation between chromosomes 1p34 and 13q 13 cosegregating with congenital facial diplegia Clinical data and flexion finger contractures in seven family members over three generations (Ziter et al., 1977) and a deletion of Nineteen patients with MBS were clinically evaluated chromosome l 3q 12.2 in a 2.5-year-old gir! with MBS with the collaboration between Department of Medical were reported (Slee et al., 1991). Therefore, it was sug­ Genetics, and Department of Pediatric Neurology, Istanbul gested that the gene responsible for MBS might be located Medical Faculty, Istanbul University, Turkey; Department on chromosome 13ql2.2-ql3. of Medical Genetics, Cerrahpasa Medical Faculty, lstanbul in this study, we screened two candidate genes, BASP I University; Department of Genetics, Zeynep Kamil Gyne­ and transcribed processed pseudogene BASP I (TP'l'g­ cologic and Pediatric Training and Research Hospital, BASP J}, in nineteen patients diagnosed with MBS. BASPI Turkey. Clinical findings of the patients are presented was selected because its orthologous gene is located within in Table 1. AII the patients had cytogenetically normal the region where the causative gene responsible for ab­ karyotype, except for MBS-12 who was found normal sprouting or branching of the facia! nerve was 46, XX.[13]/47, XXX:[19] mosaic. Table 1 Clinical findings ofMöbius syndrome patients included in the present study ~S~S~S~S~S~S~S~S~S~S~S~S~S~S~S~S~SMBSMBS Patienls -1 -2 -3 -4 -5 -o -7 -8 -9 -10 -11 -12 -13 -14 -15 -16 -17 -18 -19 Gender F F M F M M M F F M F F F F M M F M M Age(years+ 4+o 3+3 1+3 2+1 2+7 5+7 5+10 3+o 0+10 0+7 1+6 1+7 7+o 3+8 8+8 3+7 9+o O+IO 13+7 montlıs) CN VIl palsy +/+ -/+ +/- +/- +/+ +/+ +/+ +/- +/+ +/- +/+ +/+ +/+ -/+ +/+ -/+ -/+ -/+ +/+ (R/L) CNVIpalsy +/+ -/+ +/+ +/+ +/+ +/+ +{- +!+ - +{+ +{+ +{+ - +/+ (R/L) CN XII palsy +/+ - +/- -/+ -1+ +{+ +{+ (R/L) CN lII palsy +!+ +!- +/+ +/- - +{+ +{+ +{+ (R/L) CN IVpalsy +{+ - (R/L) CNVpalsy + + + CNIX/X + + + + + palsies Orofııcial + + + + + + + + + + + + + + + + + + + dysmorphisın Limb + + + + + + + + + + + + + + defonnities Poland + + + + anomaly Hypogonadism + CN, cranial neıve; F, female; M, male; R, right; L, left. Abdullah Uzumcu et al./Journal ofGenetics and Genomics 36 (2009) 251-256 253 DNA iso/ation Sequencing Peripheral blood samples were collected following Sequence analyses were carried out using an automated the approval of the informed consents by the family sequencer (Applied Biosystems 3730xl, Macrogen ine., members and genomic DNA was isolated using standard Seoul, Korea). procedures. Amp/ification ofgenomic sequences Results and discussion Two mechanisms are suggested for the pathogenesis of Both coding (chr5:17328224-17329420) and non-coding MBS: 1) the interruption of the vascular supply of the exons of BASP 1 gene including putative promoter region brainstem by environmental, mechanical, and genetic juxtaposing the transcription start site ( chr5: l 7270004- causes, which would result in ischaemia predominantly 17271027), the genomic region containing TP'Pg-BASP 1 disrupting the CN VII (St Charles et al., 1993; Graf and (chrl3:22368979-22370339), and STR markers D5S2946 Shepard, 1997; Pastuszak et al., 1998; Sarnat, 2004; Smets (chr5:17293088-17293313) and D13Sl863 (chrB:22374359- et al., 2004); 2) rhombomeric maldevelopment including 22374579, UCSC Genome Browser, www.genome.ucsc. motor nuclei and axons due to a genetic defect (Verzijl et edu) were amplified from genomic DNA by touch-down al., 2003). Families with MBS showing either autosomal PCR. A final volume of 25 µL reaction mixture containing and gonosomal inheritance pattems were described 100 ng of genomic DNA, 1 x PCR butfer with (Nl4) SO , 2 4 (Krueger and Friedrich, 1963; Legum et al., 1981; Dotti et 1.5 mmol/L MgClı, 200 µmol/L dNTP, 400 µmol/L of al., 1989; Joumel et al., 1989). A putative locus for MBS each primer, 0.75 U Taq polymerase (MBI Fermentas, was reported to be located on chromosome 13ql2.2-ql3 in Elips, Turkey), and 4%-10% DMSO (AppliChem, Dateks, regards to chromosomal abnormalities identified in two Turkey) with an initial denaturation at 94°C for 4 min fol­ studies (Ziter et al., 1977; Slee et al., 1991). However, up lowed by 34-38 cycles with denaturation at 94°C for 30 s, to date, only PLXNDJ gene, located in hereditary con­ annealing between 62°C and 52°C for 30 s, and extension genital facia! paresis l (HCFPl) locus at 3q21-q22, was at 70°C for 60 s, and a final extension at 70°C for 7 min screened and excluded in isolated MBS patients (van der using a DNA Engine PTC-200 Thermal Cycler (BioRad, Zwaag et al., 2004). Medtek, Turkey). Primer sequences used in this study were A locus responsible for abnormal sprouting or branch­ as follows: BASPl-lF, 5'-GAGGTAGCGGAATCGTAGT ing of the facial and acoustic nerves, severely reduced CG-3'; BASPl-lR, 5'-CGCTGCATGAAGGGAGAG-3'; lower jaw, smaller head, and paucity of blood was mapped BASP1-2F, 5'-CCCAGAACCCCTTGCTTT-3'; BASP1-2R, within the region tlanked by Dl 5MIT280 and Dl 5MITI il 5' -CATCACTCCCAACTCCCATT-3'; PseudoBASPl-F, on mouse chromosome 15qA2-qB2 (Mar et al., 2005), 5' -GGTGGCAGTAGTGGCAGCT-3'; PseudoBASPl-R, which is syntenic to human chromosome 5pl5.l-pl52 5'-GTTGTITAGAGTCATTGGTCAGGC-3'; D5S2946-F, where human cri-du-chat syndrome locus resides. The 5'-CCACCAAAATTCCTACGTTG-3'; D5S2946-R, 5'-CT phenotype of those mice basically resembles the clinical CACCCCAGCTTCAAACT-3'; D13Sl863-F, 5'-GCAT features of MBS and the mutant gene might thus be hy­ GGACTGAACTAACAGA-3'; Dl3Sl863-R, 5'-CCTA pothesized to underlie the syndrome. Computational analyses revealed that the comparable GGTGACAGTGCGA-3'. human critical region was of ~7 Mb in length and located between CCT5 and BASP 1 genes, where a total of sixteen Polyacry/amide gel e/ectrophoresis genes reside (UCSC Genome Browser, www.genome.ucsc.
Load more

Recommended publications
  • Analysis of Gene Expression Data for Gene Ontology
    ANALYSIS OF GENE EXPRESSION DATA FOR GENE ONTOLOGY BASED PROTEIN FUNCTION PREDICTION A Thesis Presented to The Graduate Faculty of The University of Akron In Partial Fulfillment of the Requirements for the Degree Master of Science Robert Daniel Macholan May 2011 ANALYSIS OF GENE EXPRESSION DATA FOR GENE ONTOLOGY BASED PROTEIN FUNCTION PREDICTION Robert Daniel Macholan Thesis Approved: Accepted: _______________________________ _______________________________ Advisor Department Chair Dr. Zhong-Hui Duan Dr. Chien-Chung Chan _______________________________ _______________________________ Committee Member Dean of the College Dr. Chien-Chung Chan Dr. Chand K. Midha _______________________________ _______________________________ Committee Member Dean of the Graduate School Dr. Yingcai Xiao Dr. George R. Newkome _______________________________ Date ii ABSTRACT A tremendous increase in genomic data has encouraged biologists to turn to bioinformatics in order to assist in its interpretation and processing. One of the present challenges that need to be overcome in order to understand this data more completely is the development of a reliable method to accurately predict the function of a protein from its genomic information. This study focuses on developing an effective algorithm for protein function prediction. The algorithm is based on proteins that have similar expression patterns. The similarity of the expression data is determined using a novel measure, the slope matrix. The slope matrix introduces a normalized method for the comparison of expression levels throughout a proteome. The algorithm is tested using real microarray gene expression data. Their functions are characterized using gene ontology annotations. The results of the case study indicate the protein function prediction algorithm developed is comparable to the prediction algorithms that are based on the annotations of homologous proteins.
    [Show full text]
  • 1 Supporting Information for a Microrna Network Regulates
    Supporting Information for A microRNA Network Regulates Expression and Biosynthesis of CFTR and CFTR-ΔF508 Shyam Ramachandrana,b, Philip H. Karpc, Peng Jiangc, Lynda S. Ostedgaardc, Amy E. Walza, John T. Fishere, Shaf Keshavjeeh, Kim A. Lennoxi, Ashley M. Jacobii, Scott D. Rosei, Mark A. Behlkei, Michael J. Welshb,c,d,g, Yi Xingb,c,f, Paul B. McCray Jr.a,b,c Author Affiliations: Department of Pediatricsa, Interdisciplinary Program in Geneticsb, Departments of Internal Medicinec, Molecular Physiology and Biophysicsd, Anatomy and Cell Biologye, Biomedical Engineeringf, Howard Hughes Medical Instituteg, Carver College of Medicine, University of Iowa, Iowa City, IA-52242 Division of Thoracic Surgeryh, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Canada-M5G 2C4 Integrated DNA Technologiesi, Coralville, IA-52241 To whom correspondence should be addressed: Email: [email protected] (M.J.W.); yi- [email protected] (Y.X.); Email: [email protected] (P.B.M.) This PDF file includes: Materials and Methods References Fig. S1. miR-138 regulates SIN3A in a dose-dependent and site-specific manner. Fig. S2. miR-138 regulates endogenous SIN3A protein expression. Fig. S3. miR-138 regulates endogenous CFTR protein expression in Calu-3 cells. Fig. S4. miR-138 regulates endogenous CFTR protein expression in primary human airway epithelia. Fig. S5. miR-138 regulates CFTR expression in HeLa cells. Fig. S6. miR-138 regulates CFTR expression in HEK293T cells. Fig. S7. HeLa cells exhibit CFTR channel activity. Fig. S8. miR-138 improves CFTR processing. Fig. S9. miR-138 improves CFTR-ΔF508 processing. Fig. S10. SIN3A inhibition yields partial rescue of Cl- transport in CF epithelia.
    [Show full text]
  • Integrative Analysis of Genomic Amplification-Dependent Expression
    Oncogene (2020) 39:4118–4131 https://doi.org/10.1038/s41388-020-1279-3 ARTICLE Integrative analysis of genomic amplification-dependent expression and loss-of-function screen identifies ASAP1 as a driver gene in triple-negative breast cancer progression 1 1 1 2 2 Jichao He ● Ronan P. McLaughlin ● Lambert van der Beek ● Sander Canisius ● Lodewyk Wessels ● 3 3 3 1 1 Marcel Smid ● John W. M. Martens ● John A. Foekens ● Yinghui Zhang ● Bob van de Water Received: 26 September 2019 / Revised: 14 March 2020 / Accepted: 17 March 2020 / Published online: 31 March 2020 © The Author(s) 2020. This article is published with open access Abstract The genetically heterogeneous triple-negative breast cancer (TNBC) continues to be an intractable disease, due to lack of effective targeted therapies. Gene amplification is a major event in tumorigenesis. Genes with amplification-dependent expression are being explored as therapeutic targets for cancer treatment. In this study, we have applied Analytical Multi- scale Identification of Recurring Events analysis and transcript quantification in the TNBC genome across 222 TNBC tumors and identified 138 candidate genes with positive correlation in copy number gain (CNG) and gene expression. siRNA-based 1234567890();,: 1234567890();,: loss-of-function screen of the candidate genes has validated EGFR, MYC, ASAP1, IRF2BP2, and CCT5 genes as drivers promoting proliferation in different TNBC cells. MYC, ASAP1, IRF2BP2, and CCT5 display frequent CNG and concurrent expression over 2173 breast cancer tumors (cBioPortal dataset). More frequently are MYC and ASAP1 amplified in TNBC tumors (>30%, n = 320). In particular, high expression of ASAP1, the ADP-ribosylation factor GTPase-activating protein, is significantly related to poor metastatic relapse-free survival of TNBC patients (n = 257, bc-GenExMiner).
    [Show full text]
  • Integrated Analysis of the Critical Region 5P15.3–P15.2 Associated with Cri-Du-Chat Syndrome
    Genetics and Molecular Biology, 42, 1(suppl), 186-196 (2019) Copyright © 2019, Sociedade Brasileira de Genética. Printed in Brazil DOI: http://dx.doi.org/10.1590/1678-4685-GMB-2018-0173 Research Article Integrated analysis of the critical region 5p15.3–p15.2 associated with cri-du-chat syndrome Thiago Corrêa1, Bruno César Feltes2 and Mariluce Riegel1,3* 1Post-Graduate Program in Genetics and Molecular Biology, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil. 2Institute of Informatics, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil. 3Medical Genetics Service, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil. Abstract Cri-du-chat syndrome (CdCs) is one of the most common contiguous gene syndromes, with an incidence of 1:15,000 to 1:50,000 live births. To better understand the etiology of CdCs at the molecular level, we investigated theprotein–protein interaction (PPI) network within the critical chromosomal region 5p15.3–p15.2 associated with CdCs using systemsbiology. Data were extracted from cytogenomic findings from patients with CdCs. Based on clin- ical findings, molecular characterization of chromosomal rearrangements, and systems biology data, we explored possible genotype–phenotype correlations involving biological processes connected with CdCs candidate genes. We identified biological processes involving genes previously found to be associated with CdCs, such as TERT, SLC6A3, and CTDNND2, as well as novel candidate proteins with potential contributions to CdCs phenotypes, in- cluding CCT5, TPPP, MED10, ADCY2, MTRR, CEP72, NDUFS6, and MRPL36. Although further functional analy- ses of these proteins are required, we identified candidate proteins for the development of new multi-target genetic editing tools to study CdCs.
    [Show full text]
  • Identification of Differentially Expressed Genes in Human Bladder Cancer Through Genome-Wide Gene Expression Profiling
    521-531 24/7/06 18:28 Page 521 ONCOLOGY REPORTS 16: 521-531, 2006 521 Identification of differentially expressed genes in human bladder cancer through genome-wide gene expression profiling KAZUMORI KAWAKAMI1,3, HIDEKI ENOKIDA1, TOKUSHI TACHIWADA1, TAKENARI GOTANDA1, KENGO TSUNEYOSHI1, HIROYUKI KUBO1, KENRYU NISHIYAMA1, MASAKI TAKIGUCHI2, MASAYUKI NAKAGAWA1 and NAOHIKO SEKI3 1Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima 890-8520; Departments of 2Biochemistry and Genetics, and 3Functional Genomics, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan Received February 15, 2006; Accepted April 27, 2006 Abstract. Large-scale gene expression profiling is an effective CKS2 gene not only as a potential biomarker for diagnosing, strategy for understanding the progression of bladder cancer but also for staging human BC. This is the first report (BC). The aim of this study was to identify genes that are demonstrating that CKS2 expression is strongly correlated expressed differently in the course of BC progression and to with the progression of human BC. establish new biomarkers for BC. Specimens from 21 patients with pathologically confirmed superficial (n=10) or Introduction invasive (n=11) BC and 4 normal bladder samples were studied; samples from 14 of the 21 BC samples were subjected Bladder cancer (BC) is among the 5 most common to microarray analysis. The validity of the microarray results malignancies worldwide, and the 2nd most common tumor of was verified by real-time RT-PCR. Of the 136 up-regulated the genitourinary tract and the 2nd most common cause of genes we detected, 21 were present in all 14 BCs examined death in patients with cancer of the urinary tract (1-7).
    [Show full text]
  • A High-Throughput Approach to Uncover Novel Roles of APOBEC2, a Functional Orphan of the AID/APOBEC Family
    Rockefeller University Digital Commons @ RU Student Theses and Dissertations 2018 A High-Throughput Approach to Uncover Novel Roles of APOBEC2, a Functional Orphan of the AID/APOBEC Family Linda Molla Follow this and additional works at: https://digitalcommons.rockefeller.edu/ student_theses_and_dissertations Part of the Life Sciences Commons A HIGH-THROUGHPUT APPROACH TO UNCOVER NOVEL ROLES OF APOBEC2, A FUNCTIONAL ORPHAN OF THE AID/APOBEC FAMILY A Thesis Presented to the Faculty of The Rockefeller University in Partial Fulfillment of the Requirements for the degree of Doctor of Philosophy by Linda Molla June 2018 © Copyright by Linda Molla 2018 A HIGH-THROUGHPUT APPROACH TO UNCOVER NOVEL ROLES OF APOBEC2, A FUNCTIONAL ORPHAN OF THE AID/APOBEC FAMILY Linda Molla, Ph.D. The Rockefeller University 2018 APOBEC2 is a member of the AID/APOBEC cytidine deaminase family of proteins. Unlike most of AID/APOBEC, however, APOBEC2’s function remains elusive. Previous research has implicated APOBEC2 in diverse organisms and cellular processes such as muscle biology (in Mus musculus), regeneration (in Danio rerio), and development (in Xenopus laevis). APOBEC2 has also been implicated in cancer. However the enzymatic activity, substrate or physiological target(s) of APOBEC2 are unknown. For this thesis, I have combined Next Generation Sequencing (NGS) techniques with state-of-the-art molecular biology to determine the physiological targets of APOBEC2. Using a cell culture muscle differentiation system, and RNA sequencing (RNA-Seq) by polyA capture, I demonstrated that unlike the AID/APOBEC family member APOBEC1, APOBEC2 is not an RNA editor. Using the same system combined with enhanced Reduced Representation Bisulfite Sequencing (eRRBS) analyses I showed that, unlike the AID/APOBEC family member AID, APOBEC2 does not act as a 5-methyl-C deaminase.
    [Show full text]
  • Download Ppis for Each Single Seed, Thus Obtaining Each Seed’S Interactome (Ferrari Et Al., 2018)
    bioRxiv preprint doi: https://doi.org/10.1101/2021.01.14.425874; this version posted January 16, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Integrating protein networks and machine learning for disease stratification in the Hereditary Spastic Paraplegias Nikoleta Vavouraki1,2, James E. Tomkins1, Eleanna Kara3, Henry Houlden3, John Hardy4, Marcus J. Tindall2,5, Patrick A. Lewis1,4,6, Claudia Manzoni1,7* Author Affiliations 1: Department of Pharmacy, University of Reading, Reading, RG6 6AH, United Kingdom 2: Department of Mathematics and Statistics, University of Reading, Reading, RG6 6AH, United Kingdom 3: Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, WC1N 3BG, United Kingdom 4: Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, WC1N 3BG, United Kingdom 5: Institute of Cardiovascular and Metabolic Research, University of Reading, Reading, RG6 6AS, United Kingdom 6: Department of Comparative Biomedical Sciences, Royal Veterinary College, London, NW1 0TU, United Kingdom 7: School of Pharmacy, University College London, London, WC1N 1AX, United Kingdom *Corresponding author: [email protected] Abstract The Hereditary Spastic Paraplegias are a group of neurodegenerative diseases characterized by spasticity and weakness in the lower body. Despite the identification of causative mutations in over 70 genes, the molecular aetiology remains unclear. Due to the combination of genetic diversity and variable clinical presentation, the Hereditary Spastic Paraplegias are a strong candidate for protein- protein interaction network analysis as a tool to understand disease mechanism(s) and to aid functional stratification of phenotypes.
    [Show full text]
  • Homozygous Deletions Implicate Non-Coding Epigenetic Marks In
    www.nature.com/scientificreports OPEN Homozygous deletions implicate non‑coding epigenetic marks in Autism spectrum disorder Klaus Schmitz‑Abe1,2,3,4, Guzman Sanchez‑Schmitz3,5, Ryan N. Doan1,3, R. Sean Hill1,3, Maria H. Chahrour1,3, Bhaven K. Mehta1,3, Sarah Servattalab1,3, Bulent Ataman6, Anh‑Thu N. Lam1,3, Eric M. Morrow7, Michael E. Greenberg6, Timothy W. Yu1,3*, Christopher A. Walsh1,3,4,8,9* & Kyriacos Markianos1,3,4,10* More than 98% of the human genome is made up of non‑coding DNA, but techniques to ascertain its contribution to human disease have lagged far behind our understanding of protein coding variations. Autism spectrum disorder (ASD) has been mostly associated with coding variations via de novo single nucleotide variants (SNVs), recessive/homozygous SNVs, or de novo copy number variants (CNVs); however, most ASD cases continue to lack a genetic diagnosis. We analyzed 187 consanguineous ASD families for biallelic CNVs. Recessive deletions were signifcantly enriched in afected individuals relative to their unafected siblings (17% versus 4%, p < 0.001). Only a small subset of biallelic deletions were predicted to result in coding exon disruption. In contrast, biallelic deletions in individuals with ASD were enriched for overlap with regulatory regions, with 23/28 CNVs disrupting histone peaks in ENCODE (p < 0.009). Overlap with regulatory regions was further demonstrated by comparisons to the 127‑epigenome dataset released by the Roadmap Epigenomics project, with enrichment for enhancers found in primary brain tissue and neuronal progenitor cells. Our results suggest a novel noncoding mechanism of ASD, describe a powerful method to identify important noncoding regions in the human genome, and emphasize the potential signifcance of gene activation and regulation in cognitive and social function.
    [Show full text]
  • Molecular Targeting and Enhancing Anticancer Efficacy of Oncolytic HSV-1 to Midkine Expressing Tumors
    University of Cincinnati Date: 12/20/2010 I, Arturo R Maldonado , hereby submit this original work as part of the requirements for the degree of Doctor of Philosophy in Developmental Biology. It is entitled: Molecular Targeting and Enhancing Anticancer Efficacy of Oncolytic HSV-1 to Midkine Expressing Tumors Student's name: Arturo R Maldonado This work and its defense approved by: Committee chair: Jeffrey Whitsett Committee member: Timothy Crombleholme, MD Committee member: Dan Wiginton, PhD Committee member: Rhonda Cardin, PhD Committee member: Tim Cripe 1297 Last Printed:1/11/2011 Document Of Defense Form Molecular Targeting and Enhancing Anticancer Efficacy of Oncolytic HSV-1 to Midkine Expressing Tumors A dissertation submitted to the Graduate School of the University of Cincinnati College of Medicine in partial fulfillment of the requirements for the degree of DOCTORATE OF PHILOSOPHY (PH.D.) in the Division of Molecular & Developmental Biology 2010 By Arturo Rafael Maldonado B.A., University of Miami, Coral Gables, Florida June 1993 M.D., New Jersey Medical School, Newark, New Jersey June 1999 Committee Chair: Jeffrey A. Whitsett, M.D. Advisor: Timothy M. Crombleholme, M.D. Timothy P. Cripe, M.D. Ph.D. Dan Wiginton, Ph.D. Rhonda D. Cardin, Ph.D. ABSTRACT Since 1999, cancer has surpassed heart disease as the number one cause of death in the US for people under the age of 85. Malignant Peripheral Nerve Sheath Tumor (MPNST), a common malignancy in patients with Neurofibromatosis, and colorectal cancer are midkine- producing tumors with high mortality rates. In vitro and preclinical xenograft models of MPNST were utilized in this dissertation to study the role of midkine (MDK), a tumor-specific gene over- expressed in these tumors and to test the efficacy of a MDK-transcriptionally targeted oncolytic HSV-1 (oHSV).
    [Show full text]
  • A High-Throughput Study in Melanoma Identifies Epithelial- Mesenchymal Transition As a Major Determinant of Metastasis
    Research Article A High-Throughput Study in Melanoma Identifies Epithelial- Mesenchymal Transition as a Major Determinant of Metastasis Soledad R. Alonso,1 Lorraine Tracey,1 Pablo Ortiz,4 Beatriz Pe´rez-Go´mez,5 Jose´ Palacios,1 Marina Polla´n,5 Juan Linares,6 Salvio Serrano,7 Ana I. Sa´ez-Castillo,6 Lydia Sa´nchez,2 Raquel Pajares,2 Abel Sa´nchez-Aguilera,1 Maria J. Artiga,1 Miguel A. Piris,1 and Jose´ L. Rodrı´guez-Peralto3 1Molecular Pathology Programme and 2Histology and Immunohistochemistry Unit, Centro Nacional de Investigaciones Oncolo´gicas; Departments of 3Pathology and 4Dermatology, Hospital Universitario 12 de Octubre; 5Centro Nacional de Epidemiologı´a, Instituto de Salud Carlos III, Madrid, Spain; and Departments of 6Pathology and 7Dermatology, Hospital Universitario San Cecilio, Granada, Spain Abstract with a less favorable prognosis as potential candidates for adjuvant Metastatic disease is the primary cause of death in cutaneous or novel therapies. malignant melanoma (CMM) patients. To understand the Currently, the prognosis of primary CMM is mainly based mechanisms of CMM metastasis and identify potential on histopathologic criteria. The most important of these is the predictive markers, we analyzed gene-expression profiles of Breslow index, although it is merely a measure of tumor depth. 34 vertical growth phase melanoma cases using cDNA micro- New molecular markers that correlate with melanoma genesis and/or progression are continuously being identified but, to date, arrays. All patients had a minimum follow-up of 36 months. Twenty-one cases developed nodal metastatic disease and 13 most of them have been obtained in experimental models and did not.
    [Show full text]
  • Phenotype Informatics
    Freie Universit¨atBerlin Department of Mathematics and Computer Science Phenotype informatics: Network approaches towards understanding the diseasome Sebastian Kohler¨ Submitted on: 12th September 2012 Dissertation zur Erlangung des Grades eines Doktors der Naturwissenschaften (Dr. rer. nat.) am Fachbereich Mathematik und Informatik der Freien Universitat¨ Berlin ii 1. Gutachter Prof. Dr. Martin Vingron 2. Gutachter: Prof. Dr. Peter N. Robinson 3. Gutachter: Christopher J. Mungall, Ph.D. Tag der Disputation: 16.05.2013 Preface This thesis presents research work on novel computational approaches to investigate and characterise the association between genes and pheno- typic abnormalities. It demonstrates methods for organisation, integra- tion, and mining of phenotype data in the field of genetics, with special application to human genetics. Here I will describe the parts of this the- sis that have been published in peer-reviewed journals. Often in modern science different people from different institutions contribute to research projects. The same is true for this thesis, and thus I will itemise who was responsible for specific sub-projects. In chapter 2, a new method for associating genes to phenotypes by means of protein-protein-interaction networks is described. I present a strategy to organise disease data and show how this can be used to link diseases to the corresponding genes. I show that global network distance measure in interaction networks of proteins is well suited for investigat- ing genotype-phenotype associations. This work has been published in 2008 in the American Journal of Human Genetics. My contribution here was to plan the project, implement the software, and finally test and evaluate the method on human genetics data; the implementation part was done in close collaboration with Sebastian Bauer.
    [Show full text]
  • A Genomic View of Estrogen Actions in Human Breast Cancer Cells by Expression Profiling of the Hormone-Responsive Transcriptome
    719 A genomic view of estrogen actions in human breast cancer cells by expression profiling of the hormone-responsive transcriptome Luigi Cicatiello1, Claudio Scafoglio1, Lucia Altucci1, Massimo Cancemi1, Guido Natoli1, Angelo Facchiano2, Giovanni Iazzetti3, Raffaele Calogero4, Nicoletta Biglia6, Michele De Bortoli5,7, Christian Sfiligoi7, Piero Sismondi6,7, Francesco Bresciani1 and Alessandro Weisz1 1Dipartimento di Patologia generale, Seconda Università degli Studi di Napoli, Vico L. De Crecchio 7, 80138 Napoli, Italy 2Istituto di Scienze dell’Alimentazione del Consiglio Nazionale delle Ricerche, Avellino, Italy 3Dipartimento di Genetica, Biologia generale e molecolare, Università di Napoli ‘Federico II’, Napoli, Italy 4Dipartimento di Scienze cliniche e biologiche, Università degli Studi di Torino, Torino, Italy 5Dipartimento di Scienze oncologiche, Università degli Studi di Torino, Torino, Italy 6Dipartimento di Discipline ostetriche e ginecologiche, Università degli Studi di Torino, Torino, Italy 7Laboratorio di Ginecologia oncologica, Istituto per la Ricerca e la Cura del Cancro, Candiolo, Italy (Requests for offprints should be addressed to A Weisz; Email: [email protected]) Abstract Estrogen controls key cellular functions of responsive cells including the ability to survive, replicate, communicate and adapt to the extracellular milieu. Changes in the expression of 8400 genes were monitored here by cDNA microarray analysis during the first 32 h of human breast cancer (BC) ZR-75·1 cell stimulation with a mitogenic dose of 17-estradiol, a timing which corresponds to completion of a full mitotic cycle in hormone-stimulated cells. Hierarchical clustering of 344 genes whose expression either increases or decreases significantly in response to estrogen reveals that the gene expression program activated by the hormone in these cells shows 8 main patterns of gene activation/inhibition.
    [Show full text]